We found that the T98G glioblastoma cell line expresses a high level of active Jak2 (ie, pJak2), and that treatment with G6 reduced Jak2/STAT3 phosphorylation in a dose-dependent manner. This evidence concerns the gene JAK2 and glioblastoma.